Celltrion Pharm Inc. manufactures and sells pharmaceutical products.  The Company products inclue drugs for for hepatic diseases, digestion, diabetes, cold and fever, anti-inflammatory, and veterinary medical products.  Celltrion also provides pharmaceutical raw materials.

Change of CEO

Outcomes of Annual Meeting of Shareholders

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Celltrion Pharm (068760 KS)

Change of CEO

Outcomes of Annual Meeting of Shareholders

Submission of Audit Report

[Revised] Resolutions for Convocation of General Meeting of Shareholders

Resolutions for Convocation of General Meeting of Shareholders

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)